The molecular basis of HIV capsid assembly - Five years of progress

Reviews in Medical Virology

Volumn 14, Issue 2, 2004, Pages 107-121

  Adamson, Catherine S ^a   Jones, Ian M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GAG PROTEIN; GENOMIC RNA; VIRUS ENVELOPE PROTEIN;

CELL INTERACTION; CELL SURFACE; GROUP SPECIFIC ANTIGEN GENE; HUMAN IMMUNODEFICIENCY VIRUS; LIFE CYCLE; MOLECULAR INTERACTION; NONHUMAN; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS GENE; VIRUS PARTICLE;

CAPSID; CELL MEMBRANE; GENE PRODUCTS, GAG; HIV; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RNA, VIRAL; VIRUS ASSEMBLY;

EID: 1542284115     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.418     Document Type: Review

References (140)

1. Jones IM, Morikawa Y. The molecular basis of HIV capsid assembly. Rev Med Virol 1998; 8: 87-95.
2. Vogt VM, Simon MN. Mass determination of Rous sarcoma virus virions by scanning transmission electron microscopy. J Virol 1999; 73: 7050-7055.
3. Scarlata S, Carter C. Role of HIV-1 Gag domains in viral assembly. Biochim Biophys Acta 2003; 1614: 62-72.
4. Chazal N, Gay B, Carriere C, Tournier J, Boulanger P. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway. J Virol 1995; 69: 365-375.
5. Freed EO, Orenstein JM, Buckler-White AJ, Martin MA. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J Virol 1994; 68: 5311-5320.
6. Morikawa Y, Kishi T, Zhang WH, Nermut MV, Hockley DJ, Jones IM. A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17. J Virol 1995; 69: 4519-4523.
7. Cannon WV, Chaney MK, Wang X, Buck M. Two domains within sigmaN (sigma54) cooperate for DNA binding. Proc Natl Acad Sci USA 1997; 94: 5006-5011.
8. Hill CP, Worthylake D, Bancroft DP, Christensen AM, Sundquist WI. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci USA 1996; 93: 3099-3104.
9. Rao Z, Belyaev AS, Fry E, Roy P, Jones IM, Stuart DI. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 1995; 378: 743-747.
10. Nermut MV, Hockley DJ, Jowett JBM, Jones IM, Garreau M, Thomas D. Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus. Virology 1994; 198: 288-296.
11. Morikawa Y, Zhang WH, Hockley DJ, Nermut MV, Jones IM. Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17. J Virol 1998; 72: 7659-7663.
12. Morikawa Y, Hockley DJ, Nermut MV, Jones IM. Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly. J Virol 2000; 74: 16-23.
13. Nermut MV, Hockley DJ, Bron P, Thomas D, Zhang WH, Jones IM. Further evidence for hexagonal organization of HIV gag protein in prebudding assemblies and immature virus-like particles. J Struct Biol 1998; 123: 143-149.
14. Gonzalez SA, Affranchino JL, Gelderblom HR, Burny A. Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. Virology 1993; 194: 548-556.
15. Giddings AM, Ritter GD Jr, Mulligan MJ. The matrix protein of HIV-1 is not sufficient for assembly and release of virus-like particles. Virology 1998; 248: 108-116.
16. Accola MA, Strack B, Gottlinger HG. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J Virol 2000; 74: 5395-5402.
17. Borsetti A, Ohagen A, Gottlinger HG. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J Virol 1998; 72: 9313-9317.
18. Lee PP, Linial ML. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J Virol 1994; 68: 6644-6654.
19. Reil H, Bukovsky AA, Gelderblom HR, Gottlinger HG. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J 1998; 17: 2699-2708.
20. Wang CT, Barklis E. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J Virol 1993; 67: 4264-4273.
21. Wang CT, Lai HY, Li JJ. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release. J Virol 1998; 72: 7950-7959.
22. Nermut MV, Zhang WH, Francis G, Ciampor F, Morikawa Y, Jones IM. Time course of Gag protein assembly in HIV-1-infected cells: a study by immunoelectron microscopy. Virology 2003; 305: 219-227.
23. Campbell S, Fisher RJ, Towler EM, et al. Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc Natl Acad Sci USA 2001; 98: 10875-10879.
24. Berthet-Colominas C, Monaco S, Novelli A, Sibai G, Mallet F, Cusack S. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J 1999; 18: 1124-1136.
25. Gitti RK, Lee BM, Walker J, Summers MF, Yoo S, Sundquist WI. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 1996; 273: 231-235.
26. Gamble TR, Vajdos FF, Yoo S, et al. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 1996; 87: 1285-1294.
27. Gamble TR, Yoo S, Vajdos FF, et al. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 1997; 278: 849-853.
28. Momany C, Kovari LC, Prongay AJ, et al. Crystal structure of dimeric HIV-1 capsid protein. Nat Struct Biol 1996; 3: 763-770.
29. Worthylake DK, Wang H, Yoo S, Sundquist WI, Hill CP. Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution. Acta Crystallogr D Biol Crystallogr 1999; 55: 85-92.
30. Ono A, Demirov D, Freed EO. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. J Virol 2000; 74: 5142-5150.
31. 2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication. Virology 2000; 268: 294-307.
32. Kong LB, An D, Ackerson B, et al. Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop. J Virol 1998; 72: 4403-4407.
33. Von Schwedler UK, Stray KM, Garrus JE, Sundquist WI. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol 2003; 77: 5439-5450.
34. Rose S, Hensley DJ, O'Shannessy J, Culp C, Debouck C, Chaiken I. Characterisation of HIV-1 p24 self-association using affinity chromatography. Proteins 1992; 13: 112-119.
35. Burniston MT, Cimarelli A, Colgan J, Curtis SP, Luban J. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein. J Virol 1999; 73: 8527-8540.
36. Wills JW, Craven RC. Form, function, and use of retroviral gag proteins. AIDS 1991; 5: 639-654.
37. Provitera P, Goff A, Harenberg A, Bouamr F, Carter C, Scarlata S. Role of the major homology region in assembly of HIV-1 Gag. Biochemistry 2001; 40: 5565-5572.
38. Liang C, Hu J, Whitney JB, Kleiman L, Wainberg MA. A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the gag protein of human immunodeficiency virus type 1. J Virol 2003; 77: 1772-1783.
39. Accola MA, Hoglund S, Gottlinger HG. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly. J Virol 1998; 72: 2072-2078.
40. Krausslich HG, Facke M, Heuser AM, Konvalinka J, Zentgraf H. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J Virol 1995; 69: 3407-3419.
41. Liang C, Hu J, Russell RS, Roldan A, Kleiman L, Wainberg MA. Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag. J Virol 2002; 76: 11729-11737.
42. Jowett JB, Hockley DJ, Nermut MV, Jones IM. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation [published erratum appears in J Gen Virol 1993; 74: 943]. J Gen Virol 1992; 73: 3079-3086.
43. Jowett JB, Hockley DJ, Nermut MV, Jones IM. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation [published erratum appears in J Gen Virol 1993; 74: 943]. J Gen Virol 1992; 73: 3079-3086.
44. Cimarelli A, Sandin S, Hoglund S, Luban J. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J Virol 2000; 74: 3046-3057.
45. Zabransky A, Hunter E, Sakalian M. Identification of a minimal HIV-1 gag domain sufficient for self-association. Virology 2002; 294: 141-150.
46. Sandefur S, Smith RM, Varthakavi V, Spearman P. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). J Virol 2000; 74: 7238-7249.
47. Sandefur S, Varthakavi V, Spearman P. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag. J Virol 1998; 72: 2723-2732.
48. Cimarelli A, Luban J. Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues. J Virol 2000; 74: 6734-6740.
49. Dawson L, Yu XF. The role of nucleocapsid of HIV-1 in virus assembly. Virology 1998; 251: 141-157.
50. Amarasinghe GK, De Guzman RN, Turner RB, Chancellor KJ, Wu ZR, Summers MF. NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition. J Mol Biol 2000; 301: 491-511.
51. Campbell S, Vogt VM. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol 1995; 69: 6487-6497.
52. Ott DE, Coren LV, Chertova EN, et al. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant. J Virol 2003; 77: 5547-5556.
53. Zhang Y, Qian H, Love Z, Barklis E. Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain. J Virol 1998; 72: 1782-1789.
54. Ohagen A, Luftig RB, Reicin AS, et al. The morphology of the immature HIV-1 virion. Virology 1997; 228: 112-114.
55. Gelderblom HR, Hausmann EH, Ozel M, Pauli G, Koch MA. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 1987; 156: 171-176.
56. Campbell S, Rein A. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol 1999; 73: 2270-2279.
57. Lingappa JR, Hill RL, Wong ML, Hegde RS. A multistep, ATP-dependent pathway for assembly of human immunodeficiency virus capsids in a cell-free system. J Cell Biol 1997; 136: 567-581.
58. Morikawa Y, Goto T, Sano K. In vitro assembly of human immunodeficiency virus type 1 Gag protein. J Biol Chem 1999; 274: 27997-28002.
59. Spearman P, Ratner L. Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates. J Virol 1996; 70: 8187-8194.
60. Singh AR, Hill RL, Lingappa JR. Effect of mutations in Gag on assembly of immature human immunodeficiency virus type 1 capsids in a cell-free system. Virology 2001; 279: 257-270.
61. Zimmerman C, Klein KC, Kiser PK, et al. Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature 2002; 415: 88-92.
62. Tritel M, Resh MD. Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates. J Virol 2000; 74: 5845-5855.
63. Gheysen D, Jacobs E, De Foresta F, Thines D, De Wilde M. Assembly and release of HIV-1 precursor Pr55Gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 1989; 59: 103-112.
64. Rhee SS, Hunter E. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell 1990; 63: 77-86.
65. Yuan X, Yu X, Lee TH, Essex M. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol 1993; 67: 6387-6394.
66. Morikawa Y, Hinata S, Tomoda H, et al. Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding. J Biol Chem 1996; 271: 2868-2873.
67. Spearman P, Horton R, Ratner L, Kuli-Zade I. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J Virol 1997; 71: 6582-6592.
68. Lee YM, Yu XF. Identification and characterization of virus assembly intermediate complexes in HIV-1-infected CD4+ T cells. Virology 1998; 243: 78-93.
69. Lee YM, Liu B, Yu XF. Formation of virus assembly intermediate complexes in the cytoplasm by wildtype and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes. J Virol 1999; 73: 5654-5662.
70. Ono A, Freed EO. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J Virol 1999; 73: 4136-4144.
71. Ono A, Orenstein JM, Freed EO. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J Virol 2000; 74: 2855-2866.
72. Paillart JC, Gottlinger HG. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting. J Virol 1999; 73: 2604-2612.
73. Bouamr F, Scarlata S, Carter C. Role of myristylation in HIV-1 Gag assembly. Biochemistry 2003; 42: 6408-6417.
74. Hermida-Matsumoto L, Resh MD. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA. J Virol 1999; 73: 1902-1908.
75. Platt EJ, Haffar OK. Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain. Proc Natl Acad Sci USA 1994; 91: 4594-4598.
76. Spearman P, Wang JJ, Vander Heyden N, Ratner L. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol 1994; 68: 3232-3242.
77. Zhou W, Parent LJ, Wills JW, Resh MD. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol 1994; 68: 2556-2569.
78. Zhou W, Resh MD. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J Virol 1996; 70: 8540-8548.
79. Rey O, Canon J, Krogstad P. HIV-1 Gag protein associates with F-actin present in microfilaments. Virology 1996; 220: 530-534.
80. Krausslich HG, Welker R. Intracellular transport of retroviral capsid components. Curr Top Microbiol Immunol 1996; 214: 25-63.
81. Perrin-Tricaud C, Davoust J, Jones IM. Tagging the human immunodeficiency virus gag protein with green fluorescent protein. Minimal evidence for colocalisation with actin. Virology 1999; 255: 20-25.
82. Ibarrondo FJ, Choi R, Geng YZ, et al. HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. AIDS Res Hum Retroviruses 2001; 17: 1489-1500.
83. Wilk T, Gowen B, Fuller SD. Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. J Virol 1999; 73: 1931-1940.
84. Liu B, Dai R, Tian CJ, Dawson L, Gorelick R, Yu XF. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J Virol 1999; 73: 2901-2908.
85. Hermida-Matsumoto L, Resh MD. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol 2000; 74: 8670-8679.
86. Ding L, Derdowski A, Wang JJ, Spearman P. Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts. J Virol 2003; 77: 1916-1926.
87. Holm K, Weclewicz K, Hewson R, Suomalainen M. Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J Virol 2003; 77: 4805-4817.
88. Lindwasser OW, Resh MD. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J Virol 2001; 75: 7913-7924.
89. Nguyen DH, Hildreth JE. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000; 74: 3264-3272.
90. Ono A, Freed EO. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci USA 2001; 98: 13925-13930.
91. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998; 14: 111-136.
92. Brown DA, London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 2000; 275: 17221-17224.
93. Pralle A, Keller P, Florin EL, Simons K, Horber JK. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J Cell Biol 2000; 148: 997-1008.
94. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569-572.
95. Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci USA 1991; 88: 3195-3199.
96. Huang M, Orenstein JM, Martin MA, Freed EO. p6Gag is required for particle production from full length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol 1995; 69: 6810-6818.
97. Xiang Y, Cameron CE, Wills JW, Leis J. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol 1996; 70: 5695-5700.
98. Yasuda J, Hunter E. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J Virol 1998; 72: 4095-4103.
99. Yuan B, Campbell S, Bacharach E, Rein A, Goff SP. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J Virol 2000; 74: 7250-7260.
100. Puffer BA, Watkins SC, Montelaro RC. Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly. J Virol 1998; 72: 10218-10221.
101. Craven RC, Harty RN, Paragas J, Palese P, Wills JW. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J Virol 1999; 73: 3359-3365.
102. Harty RN, Paragas J, Sudol M, Palese P. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol 1999; 73: 2921-2929.
103. Jayakar HR, Murti KG, Whitt MA. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol 2000; 74: 9818-9827.
104. Martin-Serrano J, Zang T, Bieniasz PD. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 2001; 7: 1313-1319.
105. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci USA 2000; 97: 13871-13876.
106. Parent LJ, Bennett RP, Craven RC, et al. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J Virol 1995; 69: 5455-5460.
107. Freed EO. Viral late domains. J Virol 2002; 76: 4679-4687.
108. Garrus JE, von Schwedler UK, Pornillos OW, et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001; 107: 55-65.
109. VerPlank L, Bouamr F, LaGrassa TJ, et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci USA 2001; 98: 7724-7729.
110. Pornillos O, Alam SL, Davis DR, Sundquist WI. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat Struct Biol 2002; 9: 812-817.
111. Pornillos O, Alam SL, Rich RL, Myszka DG, Davis DR, Sundquist WI. Structure and functional interactions of the Tsg101 UEV domain. EMBO J 2002; 21: 2397-2406.
112. Demirov DG, Ono A, Orenstein JM, Freed EO. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci USA 2002; 99: 955-960.
113. Bishop N, Woodman P. TSG101/mammalian VPS23 and mammalian VPS28 interact directly and are recruited to VPS4-induced endosomes. J Biol Chem 2001; 276: 11735-11742.
114. Martin-Serrano J, Zang T, Bieniasz PD. Role of ESCRT-I in retroviral budding. J Virol 2003; 77: 4794-4804.
115. Tritel M, Resh MD. The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process. J Virol 2001; 75: 5473-5481.
116. Katzmann DJ, Babst M, Emr SD. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 2001; 106: 145-155.
117. Schubert U, Ott DE, Chertova EN, et al. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci USA 2000; 97: 13057-13062.
118. Vogt VM. Ubiquitin in retrovirus assembly: actor or bystander? Proc Natl Acad Sci USA 2000; 97: 12945-12947.
119. Pelchen-Matthews A, Kramer B, Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 2003; 162: 443-455.
120. Freed EO. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 1998; 251: 1-15.
121. Hoglund S, Ofverstedt LG, Nilsson A, et al. Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res Hum Retroviruses 1992; 8: 1-7.
122. Jacks T, Power MD, Masiarz FR, Luciw PA, Barr PJ, Varmus HE. Characterization of ribosomal frame-shifting in HIV-1 gag-pol expression. Science 1988; 331: 280-283.
123. Park J, Morrow CD. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles. J Virol 1992; 66: 6304-6313.
124. Kaplan AH, Zack JA, Knigge M, et al. Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of non-infectious particles. J Virol 1993; 67: 4050-4055.
125. Kaplan AH, Manchester M, Swanstrom R. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J Virol 1994; 68: 6782-6786.
126. Adamson CS, Nermut M, Jones IM. Control of human immunodeficiency virus type-1 protease activity in insect cells expressing Gag-Pol rescues assembly of immature but not mature virus-like particles. Virology 2003; 308: 157-165.
127. Wiegers K, Rutter G, Kottler H, Tessmer U, Hohenberg H, Krausslich HG. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J Virol 1998; 72: 2846-2854.
128. Morikawa Y, Shibuya M, Goto T, Sano K. In vitro processing of human immunodeficiency virus type 1 Gag virus-like particles. Virology 2000; 272: 366-374.
129. Tang C, Ndassa Y, Summers MF. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat Struct Biol 2002; 9: 537-543.
130. Gross I, Hohenberg H, Huckhagel C, Krausslich HG. N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J Virol 1998; 72: 4798-4810.
131. von Schwedler UK, Stemmler TL, Klishko VY, et al. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J 1998; 17: 1555-1568.
132. Gross I, Hohenberg H, Wilk T, et al. A conformational switch controlling HIV-1 morphogenesis. EMBO J 2000; 19: 103-113.
133. Fuller SD, Wilk T, Gowen BE, Krausslich HG, Vogt VM. Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle. Curr Biol 1997; 7: 729-738.
134. Wilk T, Fuller SD. Towards the structure of the human immunodeficiency virus: divide and conquer. Curr Opin Struct Biol 1999; 9: 231-243.
135. Wilk T, Gross I, Gowen BE, et al. Organization of immature human immunodeficiency virus type 1. J Virol 2001; 75: 759-771.
136. Briggs JA, Wilk T, Welker R, Krausslich HG, Fuller SD. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J 2003; 22: 1707-1715.
137. Barklis E, McDermott J, Wilkens S, Fuller S, Thompson D. Organization of HIV-1 capsid proteins on a lipid monolayer. J Biol Chem 1998; 273: 7177-7180.
138. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. Assembly and analysis of conical models for the HIV-1 core. Science 1999; 283: 80-83.
139. Welker R, Hohenberg H, Tessmer U, Huckhagel C, Krausslich HG. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J Virol 2000; 74: 1168-1177.
140. Li S, Hill CP, Sundquist WI, Finch JT. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 2000; 407: 409-413.